Skip to main content
Equibles

ADAR1 Capital Management, LLC

Position in ANL — Adlai Nortye Group Ltd.

CIK 1940272 AUSTIN, TX
Back to ANL Full portfolio

Position in ANL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,704,757
+$10,888,827 QoQ
Shares Held
1,017,805
+763.2% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#8
of 42 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. ANL ranks #39 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,804,703 $240,494,721
2 PTGX
Protagonist Therapeutics, Inc
 960,863 $117,782,586
3 ROIV
Roivant Sciences Ltd.
 3,157,008 $111,726,513
4 IMVT
Immunovant, Inc.
 2,330,716 $89,802,487
5 ZLAB
Zai Lab Ltd
 3,369,034 $64,011,646
6 AGIO
Agios Pharmaceuticals, Inc.
 1,288,053 $47,799,646
7
1,222,080 $45,730,233
8 CYTK
Cytokinetics Inc
 457,907 $39,009,097

All Filings in ANL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,704,757 1,017,805
2026-03-31 $815,930 117,909